For the millions who suffer from dry eye syndrome, there is a treatment that can relieve their symptoms. OptiLight by Lumenis is an innovator in care, being the only FDA-approved treatment for dry eye disease that results from Meibomian gland dysfunction. It is a non-invasive, completely safe, and comfortable procedure that can reduce symptoms of dry eye such as:
OptiLight by Lumenis is a eye care treatment that is non-invasive and performed in the area underneath the eye. It is an effective treatment for dry eye syndrome and is backed by over 20 clinical studies.
The process typically takes about four treatment sessions that are spaced anywhere from two to four weeks apart. The sessions only take about 10 to 15 minutes and there is no downtime or recovery needed. An eye care professional applies a gel to the area that will be treated, covers your eyes with a shield, and the light pulses are focused directly below the eye.
Although some patients feel a warming sensation, most do not feel anything at all. When finished, the eye shields and gel are removed and you can get back to your day. Most patients notice improvements within two to three sessions.